Chemesis International Inc. (CSE:CSI) is a cannabis company expanding its presence across newly compliant dispensaries across California. Having established their presence in the Golden State, the company is looking to expand their operations in Latin America, where the medicinal cannabis industry is growing.

In an interview with James West from Midas Letter, Chemesis CEO Edgar Montero provided an overview of the company’s operations in California, where the company has deployed its California Sap brand and has also acquired Desert Zen, a fully compliant manufacturing and distribution company. Montero also gave viewers insight into the current regulations in the Californian market, which set strict parameters for the distribution and sale of cannabis products. As dispensaries come online with regulations launched in July 1, 2018, Chemesis is building relationships with more of these.

In his interview, Montero also addressed the company’s Latin American expansion plans. From his perspective, the Latin American market is anticipating further legalization and growth, akin to that which we have seen in Canada and the US. Seeing the potential for the size of the market, Chemesis is looking into building relationships with existing actors in the cannabis space.

“Remember that Latin America, it’s a market itself, and you need to build a relationship,” he said. “You need to do your due diligence very properly, because it’s a market that requires a very tight relationship, and this is what we’re working on right now.”

Moving forward, the company is also focused on building shareholder value. This is tied to the company’s recent $25 million equity financing agreement with Alumina Partners, which Montero believes is a key milestone for Chemesis.

To watch the full interview, click here.

Click here to connect with Chemesis International Inc. (CSE:CSI) for an investor presentation.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less